Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Psoriasis and Psoriatic Arthritis
2009-017525-19Phase 2Completed
- Sponsor
- St. Vincent's University Hospital
- Start
- Jan 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of abatacept in psoriatic arthritis (PsA) and psoriasis, sponsored by St. Vincent's University Hospital. Primary endpoint: Change in immunohistochemical markers of synovial inflammation. Started Jan 2010; status: completed.
02
Drugs
abatacept
03
Conditions
psoriatic arthritis (PsA)psoriasis
Beyond the preview
Go deeper on 2009-017525-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017525-19.